Announcements from Department of Health
03 . 06 . 2025
Please note the following announcement from Department of Health:
- Guidance for Cell and Tissue Products
- European Union: Changes to the use of antibiotic azithromycin
- Application for Clinic Licence and Request for Letter of Exemption for Small Practice Clinic under the Private Healthcare Facilities Ordinance
- FDA requires warning about rare but severe itching after stopping long-term use of oral allergy medicines cetirizine or levocetirizine (Zyrtec, Xyzal, and other trade names)
- Measures to minimise risk of suicidal thoughts with finasteride and dutasteride medicines